ORIGINAL PAPER
A series of fungal infections with rare presentation in critically ill patients: diagnostic and treatment challenges
 
More details
Hide details
1
Critical Care, University Hospital Attikon
 
2
Radiology, University Hospital Attikon
 
3
Pathology, University Hospital Attikon
 
 
Corresponding author
Frantzeska Frantzeskaki
Department of Critical Care Medicine, University Hospital Attikon, Medical School, University of Athens 1 Rimini str, 12462 Haidari, Athens Greece
 
 
Pneumon 2015;28(2):167-172
 
KEYWORDS
ABSTRACT
Invasive fungal infections are alarmingly common in ICU patients, associated with increased morbidity and mortality. Risk factors are the increased use of indwelling central venous catheters, the use of broad spectrum antibiotics, parenteral nutrition, renal replacement therapy and immunosuppression. Diagnosis of these infections might be complicated, requiring tissue cultures. Additionally, therapy of invasive fungal infections might be difficult, given the rising resistance of fungi to antifungal agents. We present three rare cases of fungal infections in critically ill patients: a Candida albicans pyelonephritis, a Candida albicans thrombophlebitis of central veins and an orofacial mucormycosis. Difficult to treat fungal infections may complicate the clinical course of critically ill patients and render their prognosis unfavorable.
REFERENCES (22)
1.
Dimopoulos G, Ntziora F, Rachiotis G, et al. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008;106:523-9.
 
2.
Prowle JR, Echeverri JE, Ligabo EV, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 2011;15:R100.
 
3.
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
 
4.
Blot S, Dimopoulos G, Rello J et al. Is Candida really a threat in the ICU? Curr Opin Crit Care 2008; 14:600-4.
 
5.
Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001;32:1602-7 Tuon FF, Costa SF.
 
6.
Caccese R, Carfagna P, Pistilli N, et al. Candidal thrombophlebitis of central veins: case report and review. Med Mycology 2012;50:299-304.
 
7.
Benoit D, Decruyenaere J, Vandewoude K, et al. Management of candidal thrombophlebitis of the central veins: case report and review. Clin Infect Dis 1998;26:26-31.
 
8.
Jarrett F, Maki DG, Chan CK. Management of septic thrombosis of the inferior vena cava caused by Candida. Arch Surg 1978;113:637-639.
 
9.
Y.A.W.F. Kelly RF. Candida thrombosis of the innominate vein with septic pulmonary emboli. Ann Vasc Surg 1993;7:343-7.
 
10.
Hoffman MJ, Greenfield LJ. Central venous septic thrombosis managed by superior vena cava Greenfield filter and venous thrombectomy: a case report. J Vasc Surg 1986;4:906-11.
 
11.
Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10(Suppl 1):31-47.
 
12.
Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S44-54.
 
13.
Varghese A, Thomas S. Orbital apex syndrome secondary to mucormycosis after a tooth extraction in an immunocompetent patient. Ear Nose Throat J 2010;89:E24-6.
 
14.
Dua R, Poate T, Abe F, et al. Lingual necrosis secondary to mucormycosis. Br J Oral Maxillofac Surg 2012;50:96-8.
 
15.
Shetty S, Kini U, Joy R. Isolated lingual mucormycosis in an infant with Down syndrome. Ear Nose Throat J 2008;1:34-8.
 
16.
Paydas S, Yavuz S, Disel U, et al. Mucormycosis of the tongue in a patient with acute lymphoblastic leukemia: a possible relation with use of a tongue depressor. Am J Med 2003;7:618-20.
 
17.
Chakrabarti A, Kumar P, Padhye AA, et al. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin Infect Dis 1997;4:500-3.
 
18.
P. NA. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine (Baltimore) 1986;2:113-23.
 
19.
Tobón AM, Arango M, Fernández D, et al. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003;11:1488-91.
 
20.
Rabie NB, Althaqafi AO. Rhizopus-associated soft tissue infection in an immunocompetent air-conditioning technician after a road traffic accident: a case report and review of the literature. J Infect Public Health 2012;1:109-11.
 
21.
Ullmann AJ, Cornely OA, Donnelly J, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 2012;18(Suppl 7):1-8.
 
22.
Cornely OA, Arikan-Akdagli S, Dannaoui E, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014;20(Suppl 3):5-26.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top